Ascend Wellness Holdings (AAWH) Accounts Payables (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Accounts Payables of $62.6 million for Q1 2026, up 14.63% year-over-year from $54.6 million in Q1 2025, and down 26.14% quarter-over-quarter from $84.8 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Accounts Payables (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Accounts Payables history runs 7 years deep, the most recent figure standing at $62.6 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 14.63% year-over-year to $62.6 million; the TTM figure through Mar 2026 stood at $62.6 million (up 14.63% YoY), while the FY2025 annual figure was $84.8 million, up 42.67% from the prior year.
- Accounts Payables for Q1 2026 stood at $62.6 million, down from $84.8 million in the prior quarter.
- The five-year high for Accounts Payables was $84.8 million in Q4 2025, with the low at $46.8 million in Q1 2022.
- The 5-year median for Accounts Payables is $59.4 million (2024), against an average of $61.3 million.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables soared 87.37% in 2022, then dropped 22.04% in 2025.
- Ascend Wellness Holdings' Accounts Payables stood at $56.6 million in 2022, then gained by 25.65% to $71.1 million in 2023, then dropped by 16.42% to $59.4 million in 2024, then soared by 42.67% to $84.8 million in 2025, then decreased by 26.14% to $62.6 million in 2026.
- Business Quant data shows AAWH's Accounts Payables at $62.6 million in Q1 2026, $84.8 million in Q4 2025, and $58.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 356.00 Mn |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 69.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.92 Mn |
| Mar 31, 2026 | 62.63 Mn |
| Dec 31, 2025 | 84.79 Mn |
| Sep 30, 2025 | 58.10 Mn |
| Jun 30, 2025 | 63.18 Mn |
| Mar 31, 2025 | 54.64 Mn |
| Dec 31, 2024 | 59.44 Mn |
| Sep 30, 2024 | 58.89 Mn |
| Jun 30, 2024 | 70.84 Mn |
| Mar 31, 2024 | 70.08 Mn |
| Dec 31, 2023 | 71.11 Mn |
| Sep 30, 2023 | 54.58 Mn |
| Jun 30, 2023 | 59.95 Mn |
| Mar 31, 2023 | 53.00 Mn |
| Dec 31, 2022 | 56.60 Mn |
| Sep 30, 2022 | 56.95 Mn |
| Jun 30, 2022 | 59.97 Mn |
| Mar 31, 2022 | 46.77 Mn |
| Dec 31, 2021 | 45.45 Mn |
| Sep 30, 2021 | 30.40 Mn |